Arrogene, Inc. Alternatives & Competitors
12 companies similar to Arrogene, Inc. — Innovative cancer treatment technology delivering advanced nano agents to target...
Companies similar to Arrogene, Inc.
Cvergenx
An innovative leader in cancer molecular diagnostics, delivering personalized radiation th...
Tampa, United States
BoomRay Pharmaceuticals
成为国际一流、品质卓越的放射性药物公司 Global pioneer in radiopharmaceuticals and commitme...
Suzhou, China
Soricimed Biopharma Inc.
Dedicated to developing effective and novel targeted treatments for cancer.
Canada
ViewRay, Inc.
Conquer cancer by re-envisioning radiation therapy.
United States
Rival Readout
Competing with Arrogene, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Genus Oncology LLC
Discovering New Frontiers in Anti-Cancer Therapeutics: Targeting MUC1 for a Healthier Tomo...
Viewpoint Molecular Targeting, Inc.
Targeted α-Particle Radiotherapy for Cancer
Coralville, United States
OncoPep, Inc.
To develop and commercialize targeted immuno-therapeutics which prevent the progression of...
Boston, United States
Aurora Oncology
Pioneering targeted therapeutics to combat non-muscle invasive bladder cancer with precisi...
Alloplex Biotherapeutics Inc
A robust cellular therapeutic platform for treating cancer.
Boston, United States
Tyligand Bioscience
Innovative small molecule therapeutics for cancer and autoimmune disease treatment.
AtG Therapeutics
Overcoming Tumor Adaptation - inhibiting escape mechanisms both in treatment naive and res...
Spain
iOnctura
Developing precision small molecules to combat hard-to-treat tumors.
Geneve, Switzerland
About Arrogene, Inc.
Arrogene, Inc. is a biotechnology company founded in 2007 with a focus on developing innovative cancer treatment technologies. The company's slogan "Innovative cancer treatment technology delivering advanced nano agents to target tumors, enhancing patient outcomes and offering personalized care solutions" summarizes th...
Cancer Treatment, Nano Agents, Tumor Inhibitors, Imaging Agents, Peptide Therapeutics, Protein Therapeutics, Oligonucleotide Therapeutics, Blood-brain Barrier, Personalized Care Solutions, Nanomedicine, Precision Medicine, Oncology Technology, Targeted Therapy, Patient Outcomes
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Arrogene, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Arrogene, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 22 Jun 2024 and 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
